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Objectives: There is ambiguity concerning the walk tests available for functional assessment of coronary
patients, particularly for the walking speed. This study explores the psychometric properties of two
walking tests, based on ﬁxed-distance tests, at comfortable and fast velocity, in stabilized patients at the
end of a cardiac rehabilitation program.
Methods: At a three-day interval 58 coronary patients (mean age of 64.85  6.03 years, 50 men) performed
three walk tests, the ﬁrst two at a comfortable speed in a random order (6-minute walk test – 6MWT – and
400-metre comfortable walk test – 400mCWT) and the third at a brisk speed (200-metre fast walk test –
200mFWT). A modiﬁed Bruce treadmill test was associated at the end of the second phase. Monitored main
parameters were: heart rate, walking velocity, VO2.
Results: Tolerance to the 3 tests was satisfactory. The reliability of the main parameters was good
(intraclass correlation coefﬁcient > 0.8). The VO2 concerning 6MWT and 400mCWT were not
signiﬁcantly different (P = 0.33) and were lower to the ﬁrst ventilatory threshold determined by the
stress test (P < 0.001): 16.2  3.0 vs. 16.5  2.6 vs. 20.7  5.1 mLmin1kg1 respectively. The VO2 of the
200mFWT (20.2  3.7) was not different from the ﬁrst ventilatory threshold.
Conclusions: 400mCWT and 200mFWT are feasible, well-tolerated and reliable. They explore two levels
of effort intensity (lower and not different to the ﬁrst ventilatory threshold respectively). 400mCWT is a
possible alternative to 6MWT. Associated with 200mFWT it should allow a better measurement of
physical capacities and better customization of exercise training.




In current practice, walk tests are used in patients with various
chronic disabilities, particularly cardiovascular and respiratory
diseases, to assess their adaptation to effort and the evolution of
this under the effect of pharmacotherapies or non-pharmaco-
therapeutic interventions (such as exercise training programs). As
they more speciﬁcally explore submaximal capacities, which is the
intensity often required during daily activities, they complement
data obtained from maximum cardiopulmonary exercise testing
(CPET). Compared with the CPET, walk tests have the advantage of
requiring limited human and technological resources, and can thus
be repeated regularly. Consequently, walk tests haves been* Corresponding author. Cardiac Rehabilitation Department, CHU Dijon, 23, rue
Gaffarel, 21078 Dijon cedex, France. Tel.: +33 3 80 29 38 14; fax: +33 3 80 29 36 43.
E-mail address: jean-marie.casillas@chu-dijon.fr (J.-M. Casillas).
http://dx.doi.org/10.1016/j.rehab.2016.11.001
1877-0657/ 2016 Elsevier Masson SAS. All rights reserved.diversiﬁed and many different protocols are available: ﬁxed-
duration walking test (6-minute walk test, 2-minute walk test. . .),
ﬁxed-distance walking tests (6-metre walk test, 100-metre walk
test, 200-metre walk test, 400-metre walk test. . .) and walking
tests with incremental speed (10-metre shuttle walk test) [1]. Most
of these tests explore aerobic capacities [2]. Indeed, recommended
exercise programs in cardiovascular and respiratory diseases
mainly seek to improve the aerobic performance [3].
Walking speed appears to be the key parameter, because it
conditions the other physiological parameters such as metabolic
parameters [4]. The comfortable walking speed (or self-velocity) is
of great interest, because it represents the best bioenergetic
efﬁciency of walking, in a steady state of aerobic metabolism [5]. It
correlates with age and sex [6], it is associated with functional
capacities and global health status [7], it represents an appropriate
and well-tolerated stimulus for exercise training during cardiac
rehabilitation [8] and it is a predictive factor of mortality [9,10].
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metabolism, and, high-intensity training programs, such as
interval training, have also been validated [11], giving particular
interest to brisk walk tests, which are designed to assess tolerance
to higher levels of effort, beyond the strict aerobic limits.
Finally, the comfortable and the fast walking speed appear to
be highly complementary measurement, and for some authors the
difference between the two is the best indicator of locomotor
capacity [12].
Among current walk tests, the 6-minute walk test (6MWT) is
the most commonly used as the main parameter to assess the
impact of various therapeutic interventions in clinical practice
and during experimental studies. However, there is some
ambiguity in the instructions for the 6MWT concerning the
required walking speed. Indeed, in its initial proposal, dedicated
to heart failure patients, the 6MWT should be practiced at a self-
selected velocity [13], though recommendations are different in
other contexts. For example, for respiratory rehabilitation, the test
is designed as ‘‘the distance that a patient can walk quickly’’
[14]. This leads to divergence regarding the modalities of the
6MWT, sometimes with conditions that must be strictly aerobic
[2,12,15], and at other times with the aim to achieve an intensity
close to maximum capacity [16]. This limitation and the
heterogeneity in the available walk tests make them difﬁcult to
apply in clinical practice [17] and there are currently no
recommendations regarding their indications.
This study is the ﬁrst step in a project whose ultimate objective
is to validate a new procedure dedicated to usual applications of
walk tests. It is based on two preliminary observations: ﬁrstly, it
seems justiﬁed to favor ﬁxed-distance walking tests rather than
ﬁxed-duration walking tests (such as the 6MWT), because for
planning motor activity, the use of spatial criteria has long been
known to be more effective than time references [18,19]; secondly,
it appears appropriate to speciﬁcally evaluate two levels of walking
speed: comfortable walking speed (strictly aerobic) and fast
walking speed (exceeding the limits of strict aerobic metabolism).
For this purpose, the main objective of this study was to compare,
in stabilized coronary patients, the metrological qualities of the
400-metre comfortable walk test (400mCWT), a ﬁxed-distance
walking test at a self-pace (comfortable speed), with the reference
walk test, the 6MWT. The second objective was to compare these
two self-pace walk tests with a CPET and a fast walk test, the 200-




Participants were included without distinction of sex, if they
were aged between 55 and 80 years, at the end of an outpatient
cardiac rehabilitation program and referred for either myocardial
infarction, or coronary angioplasty (+ stenting), or coronary artery
bypass surgery, or stabilised coronary artery disease. Enrolled
subjects were excluded if they presented signiﬁcant cognitive
disorders that hampered participation in the tests (Mini Mental
State examination < 24), any cardiac rhythm other than sinus
rhythm (permanent or exercise-induced), acute or chronic
respiratory failure, any associated disease that limited walking
capacity or could stop an exercise test prematurely for a reason
other than fatigue or dyspnoea, acute or chronic heart failure (left
ventricular ejection fraction < 45% using the echocardiographic
Simpson method), renal failure, residual myocardial ischaemia,
pacemaker, severe obstructive heart disease, moderate to severe
aortic stenosis, intracavitary thrombosis, pulmonary hyperten-
sion > 70mmgHg, heart transplantation or any modiﬁcation ofdrugs affecting adaptation to effort (diuretics, angiotensin-
converting enzyme inhibitors, angiotensin receptor blockers,
beta-blockers, anti-aldosterones, ivabradine) within the 15 days
preceding the tests. Anthropometric measurements included
height, weight, and body mass index.
Written informed consent, approved by the institutional
ethics committee (Subjects Protection Committee, Dijon Est I),
was obtained for all participants, after they had been clearly
informed about the protocol. This was a prospective single-centre
study published in Clinical Trials Registration (reference
NCT01904929).
2.2. Protocol
The whole protocol was carried out on a motricity analysis
platform in a rehabilitation center of a university hospital.
2.2.1. Different phases of the protocol
The same experimental protocol was repeated at an interval of
72 hours to assess the reliability of the three walk tests (6MWT,
400mCWT, 200mFWT). A CPET, without pharmacologic wash-out,
was carried out only at the end of the second phase of the protocol.
Concerning the order of the walk tests, the two self-pace tests
(6MWT, 400mCWT) were done ﬁrst, in a random order, in order to
subject the patients to an effort of increasing intensity, thus
limiting the effects of fatigue for the brisk walk test and the CPET.
All the walk tests were conducted on the same ﬂat 50-metre-long
indoor walking track at the same time of day. The same operator
monitored the three successive tests, and the ﬁnal CPET was
supervised by a cardiologist specialised in cardiac rehabilitation.
For all the tests, the occurrence of limitations or early termination
(dizziness, chest pain, musculoskeletal pain. . .) was collected. The
protocol was preceded by a 15-minute rest phase, and each test
was separated by a new 15-minute rest period, or longer if the
heart rate (HR) had not returned to the resting HR: Goal was to
allow a sufﬁcient recovery phase between each walking test (at
least twice the duration of the test), with a return to resting levels
of physiological parameters. The monitored parameters were HR
assessed continuously by an HR monitor (POLAR FT1-Polar Electro
Oy–90440 Kempele, Finland), blood pressure in the sitting
position on the right arm before and after each test and
continuous assessment of breath-by-breath gas exchange using
a portable device (K4b2, Cosmed, Rome, Italy), VO2 and VCO2
being computed and extracted directly using the incorporated
software.
2.2.2. The 6MWT
The patients were instructed to cover as much ground as they
could during the allotted time, at their free–chosen walking speed
(comfortable self-selected speed). Running was forbidden, but
stopping and resting was allowed. No encouragement was given
during the test, but patients were informed every 2 minutes of the
time spent. The distance walked was recorded at the end of the test
as an absolute value in metres.
2.2.3. The 400mCWT
The walking speed directives were the same as for the 6MWT,
but on a ﬁxed-distance of 400 m. The test result was expressed in
seconds (time to cover the distance of 400 m).
2.2.4. The 200mFWT
The instruction was to cover a distance of 200 m as quickly as
possible, without running. Standard encouragement was provided
at mid-distance. Slowing down and stopping to rest were
authorised. The results were also given in absolute values (time
to complete the test in seconds).
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A modiﬁed Bruce treadmill test was performed with continuous
12-lead ECG monitoring (Marquette, GE Medical Systems, Mil-
waukee, USA) [20]. It was a symptom-limited maximum exercise
test. Standard encouragement was provided at the mid time of
every stage of the test to exercise patients to exhaustion. The use of
handrail support was forbidden throughout the effort test, except
in the case of a loss of balance or at the exhaustion phase at which
time the test was stopped. Blood pressure was measured at the end
of every stage of the test, at peak exercise and during recovery. The
ﬁrst ventilatory threshold was determined by the Wasserman
method [21]. The CPET was terminated at exhaustion, deﬁned as a
ﬁnal respiratory exchange ratio above 1.10. The VO2 peak was
deﬁned as the highest value during the last 60 seconds of the stress
test. The highest HR measured during the last minute of the
treadmill test was used as the reference value for the maximal HR
(HRmax).
2.3. Statistical analysis
To assess reliability, a test-retest was conducted with a single
experimenter. The intraclass correlation coefﬁcient (ICC) was
computed in order to evaluate measurement agreement. An ICC
higher than 0.7 was considered good, and over 0.9 excellent.
In order to evaluate the distribution of the difference of the
means between walk tests, Bland and Altman plots were obtained
by plotting the difference between sessions against the mean
results for HR (bpm), VO2 uptake (mLmin1kg1) and the walking
velocity (ms1). Bland and Altman representations make it
possible to describe the percentage of subjects and their
distribution within the 95% limits of agreement throughout the
range of each walk test performance. The smallest detectable
difference (SDD), which corresponds to the limits of agreement
(mean change  1.96 SD) represents the smallest change that can be
distinguished from the measurement error for each parameter.
The validity of the parameters was evaluated against the gold
standard assessment of physical capacities (i.e. measures at theAnalysed (n=29) 
♦ Excluded from  analysis for he art  rate 
(apparatus  dysfu nction) (n=8)
Analys
Allocated to  6MW T- 40 0CWT  (n=29) 




Assessed for  e 
Fig. 1. Flow diagram (CPET peak and ﬁrst ventilatory threshold). A Pearson correlation
coefﬁcient was then used and the strength of the correlation was
evaluated using Munro’s classiﬁcation system (very weak 0.15–
0.24, weak 0.25–0.49, moderate 0.50–0.69, high 0.70–0.89 and
very high 0.60–1).
The fact that we had more than 30 patients allowed us to
analyse the data with parametric tests, in accordance with central
limit theory. Differences between groups and tests were assessed
respectively with independent and paired t-test. Means and 95%
conﬁdence intervals were calculated and are presented for both
sessions of the test. Statistical analyses were done using statistica
v10.0 (StatSoft, Tulsa, USA) and Matlab with statistical toolbox
(MathWorks, Natick USA). An alpha value of 5% was chosen to
determine the signiﬁcance of the parameters.
3. Results
A total of 58 patients completed the protocol study (inclusions
carried out from November 2013 to August 2015). The ﬂow
diagram of this study is presented in Fig. 1. The baseline
characteristics of the patients are reported in Table 1.
Feasibility of the three walk tests was satisfactory, with no
symptoms of intolerance. Concerning the reliability, there was no
difference in any of the main values assessed (HR, walking velocity
and VO2 peak) for the three walk tests between the two sessions
(Table 2). However, there was a difference due to the randomiza-
tion in the ﬁrst session between the 6MWT and 400mCWT. Indeed,
walking speed was different between the two tests for the two
sessions, only when the 6MWT was performed ﬁrst (Fig. 2). This is
consistent with a lower ICC for the 6MWT. Fig. 3 shows the Bland
an Altman distribution of the three main parameters (HR, VO2 and
walking velocity) for the 6MWT, the 400mCWT and the 200mFWT.
For all values measured during the three walk tests, a difference
was found for the 200FWT only, the distribution being identical
between 6MWT and 400mCWT (see Fig. 4 for the VO2 distribution).
The mean VO2 measured during the 6MWT and 400mCWT, like
the HR, was not different, but was lower than those correspondingis
Analysed (n=29) 
♦ Excluded  from  analys is for  he art  rate 
(apparatus  dysfu nction)  (n=7)
Allocated to  400 CWT- 6MWT-  (n=2 9) 
♦ Received  allocat ed inter vention  (n=29)
Excluded (n=30) 
♦ Not  meeting  incl usion cr iteria  (n=26) 
♦ Declined  to partici pate  (n=5) 
n
ed  (n=5 8) 
ligibility (n=  89) 
CONSORT 2010).
Table 1
Characteristics of patients included in the study.
Characteristics Population (n = 58)
Sex (male/female) (50/8)
Age (years) 64.85  6.03
Height (m) 1.71  0.07
Weight (kg) 76.92  11.80
Body Mass Index (kgm2) 26.28  3.43
VO2 uptake at rest (mLmin1kg1) 4.3  0.4
Heart rate at rest (bpm) 72  3
Medications
Beta-blockers 55
Angiotensin-converting enzyme inhibitors 48






Fig. 2. Velocity histograms vs. randomization: mean walking velocity (ms1) and
standard deviation function of the randomized groups (either 6mWT in ﬁrst or
400mCWT in ﬁrst). This ﬁgure shows the interaction effect between the
randomization order and the performance of the tests.
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VO2 during the 200mFWT was not signiﬁcantly different from that
of the ﬁrst ventilatory threshold, while the HR during the
200mFWT was higher than those corresponding to the ﬁrst
ventilatory threshold (Fig. 5).
4. Discussion
Though the CPET is always proposed as the gold standard for
exercise prescription prior to a training program in cardiac
rehabilitation [22], submaximal exercise testing is being increas-
ingly developed as a complement, to better evaluate the
physiological responses to situations encountered in daily life
[23]. Among the available functional tests, the assessment of
walking activities is of great interest, especially because of the
commonly reported limitations of the compendium of physical
activities [24]. Given the heterogeneity already highlighted
regarding available walk tests and the ambiguity regarding the
exact choice of walking speed, this study is part of a global project
that attempts to validate a reasoned strategy, based on the use of
ﬁxed-distance walk tests at two speed levels: a comfortable speed,
based on the 400mCWT, and a brisk speed based on the 200mFWT.
The distance of 400 metres was chosen for the comfortable
speed test (400mCWT) because it is an average of the 6MWT
distance assessed in patients with chronic disabilities, such as
heart failure [25]. Furthermore, it includes the distance of
300 metres, which represents a threshold both functionally and
in terms of predicted mortality [26,27]. A 400-metre walk test at a
self-selected speed was ﬁrst proposed as an alternative to theTable 2
Means and 95% conﬁdent Interval (CI) of the heart rate, walking velocity and VO2 uptake (
session 1 (S1) and 2 (S2). Inter-sessions Intraclass correlation coefﬁcients (ICC) are prese
than 0.9, excellent reliability.













6MWT: 6-minute walk test; 400mCWT: 400-metre comfortable walk test; 200mFWT:6MWT in healthy subjects, walking speed and HR being higher
than for the 6MWT [28]. In contrast, in subsequent studies carried
out in older adults, the same authors used the instructions to ‘‘walk
as quickly as you can, without running’’ for this ‘‘long distance
corridor walk’’, the results (time to complete the test) being
predictive of mobility limitation and of mortality [29] and being
correlated with peak VO2 [30]. The reliability of the 400-metre
walk test at a brisk pace was shown to be excellent in healthy adult
women [31]. To our knowledge, the 400-metre walk test ‘‘at a
speed chosen by the patient himself’’ was only once implemented
in patients with heart disease. In twenty patients with chronic
heart failure, a good correlation was shown between distance
covered during the 6MWT and time recorded during the 400-metre
walk test [32].
The 200mFWT is derived from the 600-foot walking test, which
was proposed as an alternative to a CPET in elderly coronary
patients [33]. It was ﬁrst designed to assess tolerance to high-
intensity exercises in healthy elderly subjects [34]. The reliability,
validity, sensitivity to change and efﬁciency to tailor high-intensity
interval training have been found to be satisfactory in coronary
patients [35,36], but a minimal clinically important difference hasmeans of the last 30s of the test) for the 6 minute, 400 m and 200 m walk tests during
nted with their 95% CI. Values higher than 0.7 indicate good reliability, and higher
 CI) Mean S2 (95% CI) ICC (95% CI)
4.1) 94.9 (90.3–99.5) 0.822 (0.66–0.9)
5.3) 91.3 (86.9–95.7) 0.852 (0.72–0.92)
117.3) 116.4 (110–122.9) 0.814 (0.67–0.89)
6.4) 87.1 (84.7–89.6) 0.885 (0.81–0.93)
7.5) 88.1 (85.7–90.4) 0.932 (0.89–0.96)
112.4) 110.5 (107.5–113.4) 0.951 (0.92–0.97)
5.8) 16.3 (15.5–17.1) 0.824 (0.7–0.9)
6.1) 16.5 (15.8–17.2) 0.826 (0.71–0.9)
 20.3 (19.3–21.2) 0.859 (0.76–0.92)
 200-metre fast walk test.
Fig. 3. Bland-Altman plots showing the absolute differences between sessions as a function of the mean of both sessions for the 6MWT (bottom panels), 400mCWT (middle
panels) and 200mFWT (upper panels). The values of heart rate (bpm): left panels, VO2 uptake (mLmin1kg1): middle panels and walking velocity (ms1): right panels are
presented.
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measured during this walk test and the patient’s age, proved to be
more effective than the classic Fox formula (HRmax = 220 – age) to
predict the HRmax of coronary patients: HRmax = 130 –
0.6  age + 0.3  HR200mFWT [38].Fig. 4. VO2 uptake curves: mean VO2 and 95% conﬁdent interval for the 6MWT,
400mCWT and 200mFWT, expressed as the percentage duration of each test.In the present study, the reliability of these two tests, like that of
the 6MWT, was satisfactory for the three main parameters, namely
walking speed, VO2 and HR. In addition, no signiﬁcant difference
was shown for these three factors between the 400mCWT and the
6MWT. These ﬁrst results therefore suggest that the 400mCWT
could be a possible alternative to the 6MWT, especially as
randomization between the two tests showed additional interests
for the 400mCWT. In this context of a comfortable speed, the
comparison with the CPET data conﬁrms, in agreement with
previous studies [39], that aerobic capacities alone are explored by
the 6MWT and the 400mCWT (VO2 values below the ﬁrst
ventilatory threshold). In contrast, the 200mFWT effectively
corresponds to a more intense effort, the same intensity level as
the ﬁrst ventilatory threshold, which is a transition zone between a
strictly aerobic metabolism and a mixed metabolism (aerobic and
anaerobic). A low difference between the 200mFWT speed and the
400mCWT speed is probably linked to a premature recourse to the
anaerobic metabolism, corresponding maybe to a deﬁciency of the
strictly aerobic capacities. The assessment of the evolution of the
ratio of these two speeds, depending on an exercise training
program, will be of particular interest to answer this question.
There is an apparent paradox concerning the 200mFWT results,
with a not different VO2 value but a higher HR than for the ﬁrst
ventilatory threshold determined during the CPET. This can be
explained by the difference in the effort type (treadmill for CPET,
ﬂat walking track for 200mFWT) that causes different changes in
Fig. 5. Mean values and standard deviation of VO2 uptake (mLmin1kg1) (bottom)
and the heart rate (upper) for the 6MWT, 400mCWT, 200mFWT, CPET ﬁrst
anaerobic threshold (AT1) and CPET peak.
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relationship between cardiac output and peripheral oxygen
utilization in coronary patients. Pathophysiological studies are
currently lacking in this area.
The main limitation of this study is that it did not allow us to
draw any deﬁnitive conclusions about the superiority of the
400mCWT compared with the 6MWT for the functional assess-
ment of coronary patients in current practice. To meet this
objective, this study will now continue in order to evaluate, ﬁrstly
the sensitivity to change of the 400mCW (e.g. after cardiac
rehabilitation), and secondly, in the real world of the cardiac
rehabilitation, the simpliﬁcation truly provided by the preferential
use of ﬁxed-distance walk tests. Indeed, the challenge is to show
that the 400mCWT is more appropriate than the 6MWT to
determine the comfortable walking speed in everyday practice
(outside the strict conditions of an experimental protocol).
5. Conclusion
The functional assessment of stabilized coronary patients by
ﬁxed-distance walk tests at two different speeds (comfortable and
fast) is feasible, well-tolerated, and reliable. It represents a simple
and cheap procedure to assess exercise capacity at two intensity
levels. If the results of complementary studies are favorable, in the
future, it should be possible to clarify the current ambiguity
regarding the selection of the walking speed, in order to betterassess the physical capacities regularly implemented in everyday
activities and to better customize training programs.
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